Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9902214 | Journal of Immunological Methods | 2005 | 9 Pages |
Abstract
A single nucleotide polymorphism (SNP) of the FCGR3A gene results in two allotypes of Fcγ receptor IIIA (FcγRIIIA) with valine (V) or phenylalanine (F) at amino acid 158. Since the FcγRIIIA-158 V/F polymorphism is associated with the efficacy of monoclonal antibody (mAb) treatment and a risk factor for autoimmune disease, widely applicable methods to assess the SNP are needed. We developed a novel flow cytometric test for this polymorphism using a mAb that recognized only the FcγRIIIA-158 V allele (MEM-154) together with a mAb that detected both FcãRIIIA-158 alleles (3G8). The expression of both FcγRIIIA epitopes on natural killer (NK) cells from 37 healthy donors were measured and compared to the FCGR3A genotype determined by a 5Ⲡnuclease assay. FcγRIIIA expression levels in individuals with identical FCGR3A genotypes varied considerably, resulting in overlapping immunofluorescences by both 3G8 and MEM-154 between FcγRIIIA-158 V/F allotypes. However, the ratio between fluorescences measured using those mAbs in a single individual predicted the FCGR3A genotype with 100% sensitivity and specificity. The novel flow cytometric assay for the FcγRIIIA-158 V/F polymorphism that is based on the MEM-154/3G8 fluorescence ratio requires commercially available reagents and a three-color flow cytometer only.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Sebastian Böttcher, Matthias Ritgen, Monika Brüggemann, Thorsten Raff, Silke Lüschen, Andreas Humpe, Michael Kneba, Christiane Pott,